Study on efficacy of Caucasian whortleberry in the treatment of hyperlipidemic patients
- Conditions
- Hyperlipidemia.Hyperlipidemia, unspecified
- Registration Number
- IRCT201112242288N4
- Lead Sponsor
- Research Institute for Islamic and Complementary Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
patients aged 20 to 60 years, patients with serum cholesterol level above 240 mg/dl, patients with serum triglyceride level above 240 mg/dl, patients recently diagnosed as hyperlipidemic, literate patients. Exclusion criteria: patients with serum cholesterol or triglyceride levels above 300 mg/dl, patients using other blood lipid lowering agents, patients with cardiac, renal, hepatic, hematological diseases, hypothyroidism, diabetes, tachycardia, vertigo and seizure, patients with a history of gallstones or gall bladder surgery, patients using estrogen, steroid, beta-blocker and thiazide, pregnant women, women planning pregnancy, breast-feeding women.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood serum cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum triglyceride level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).
- Secondary Outcome Measures
Name Time Method Blood serum LDL cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum HDL cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum creatinine level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum SGOT level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum SGPT level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).